|
Adalimumab, 40 Mg, Injectable Solution, Recombinant Human Epoetin Alfa, 4,000 Iu, Azacitidine, 100 Mg, Lyophilic Powder For Injection, Belimumab 120 Mg Po Liof Inj Ct Fa, Belimumab, 400 Mg Po Liof Inj Ct Fa Vd, Bendamustine 100 Mg, Hydrochloride, Lyophilized Powder For Infusion (Fr-Amp)., Bendamustine 25 Mg, Benralizumab 30 Mg/Ml — Injectable Solution — Applicator Pen Containing 1 Ml., Blinatumomab 38.5Mcg/10Ml, Lyophilized Powder For Injectable Solution., Brentuximab Vedotin 50 Mg, Canakinumab, 150 Mg, Carfilzomib 60 Mg, Cemiplimab 50 Mg/7 Ml, Solution For Dilution For Infusion (Fr-Amp)., Cetuximab, 5 Mg/Ml, Daratumumab 20 Mg/20 Ml, Injectable Solution (Fr-Amp)., Daratumumab 20 Mg/ 5 Ml, Denosumab 120 Mg/1.7 Ml, Dupilumab 200Mg, Dupilumab 300Mg – Injectable Solution., Enoxaparin 40 Mg Subcutaneous Injectable Solution (0.4 Ml Syringe)., Enoxaparin 60 Mg Subcutaneous Injectable Solution (0.6 Ml Syringe.), Goserelin Acetate, 10.80 Mg, 3, 6Mg, Guselkumab 100 Mg/1 Ml, Injectable Solution, Prefilled Syringe.
|
